Global Oncology Biosimilars Market Report 2021
Global Oncology Biosimilars Market Report 2021
The report classifies the business vertical into various segments based on components, voltage, end-user scope, and regional division. A thorough analysis of each segment with respect to their market share, growth rate, and revenue contribution forms a major part of the study.
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
At the beginning of 2020, COVID-19 disease began to spread around the world, millions of people worldwide were infected with COVID-19 disease, and major countries around the world have implemented foot prohibitions and work stoppage orders. Except for the medical supplies and life support products industries, most industries have been greatly impacted, and Oncology Biosimilars industries have also been greatly affected.
In the past few years, the Oncology Biosimilars market experienced a growth of 7, the global market size of Oncology Biosimilars reached (2020 Market size XXXX) million $ in 2020, of what is about (2015 Market size XXXX) million $ in 2015.
From 2015 to 2019, the growth rate of global Oncology Biosimilars market size was in the range of xxx%. At the end of 2019, COVID-19 began to erupt in China, Due to the huge decrease of global economy; we forecast the growth rate of global economy will show a decrease of about 4%, due to this reason, Oncology Biosimilars market size in 2020 will be (2020 Market size XXXX) with a growth rate of xxx%. This is xxx percentage points lower than in previous years.
As of the date of the report, there have been more than 20 million confirmed cases of CVOID-19 worldwide, and the epidemic has not been effectively controlled. Therefore, we predict that the global epidemic will be basically controlled by the end of 2020 and the global Oncology Biosimilars market size will reach (2025 Market size XXXX) million $ in 2025, with a CAGR of xxx% between 2020-2025.
This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better. This report also covers all the regions and countries of the world, which shows a regional development status, including market size, volume and value, as well as price data.
Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers.
Section 1: Free——Definition
Section (2 3): 1200 USD——Manufacturer Detail
Celltrion Inc.
BioconSTADA Arzneimittel AG
Dr. Reddy’s Laboratories Ltd.
Pfizer Inc.
Intas Pharmaceuticals Ltd.
Sandoz International GmbH
BIOCAD
Teva Pharmaceutical Industries Ltd.
Section 4: 900 USD——Region Segmentation
North America Country (United States, Canada)
South America
Asia Country (China, Japan, India, Korea)
Europe Country (Germany, UK, France, Italy)
Other Country (Middle East, Africa, GCC)
Section (5 6 7): 500 USD——
Product Type Segmentation
Drug Class - G-CSF
Monoclonal Antibodies
Hematopoietic Agents
Industry Segmentation
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Channel (Direct Sales, Distributor) Segmentation
Section 8: 400 USD——Trend (2020-2025)
Section 9: 300 USD——Product Type Detail
Section 10: 700 USD——Downstream Consumer
Section 11: 200 USD——Cost Structure
Section 12: 500 USD——Conclusion
Section 1 Oncology Biosimilars Product Definition
Section 2 Global Oncology Biosimilars Market Manufacturer Share and Market Overview
2.1 Global Manufacturer Oncology Biosimilars Shipments
2.2 Global Manufacturer Oncology Biosimilars Business Revenue
2.3 Global Oncology Biosimilars Market Overview
2.4 COVID-19 Impact on Oncology Biosimilars Industry
Section 3 Manufacturer Oncology Biosimilars Business Introduction
3.1 Celltrion Inc. Oncology Biosimilars Business Introduction
3.1.1 Celltrion Inc. Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.1.2 Celltrion Inc. Oncology Biosimilars Business Distribution by Region
3.1.3 Celltrion Inc. Interview Record
3.1.4 Celltrion Inc. Oncology Biosimilars Business Profile
3.1.5 Celltrion Inc. Oncology Biosimilars Product Specification
3.2 BioconSTADA Arzneimittel AG Oncology Biosimilars Business Introduction
3.2.1 BioconSTADA Arzneimittel AG Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.2.2 BioconSTADA Arzneimittel AG Oncology Biosimilars Business Distribution by Region
3.2.3 Interview Record
3.2.4 BioconSTADA Arzneimittel AG Oncology Biosimilars Business Overview
3.2.5 BioconSTADA Arzneimittel AG Oncology Biosimilars Product Specification
3.3 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Introduction
3.3.1 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
3.3.2 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Distribution by Region
3.3.3 Interview Record
3.3.4 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Overview
3.3.5 Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Product Specification
3.4 Pfizer Inc. Oncology Biosimilars Business Introduction
3.5 Intas Pharmaceuticals Ltd. Oncology Biosimilars Business Introduction
3.6 Sandoz International GmbH Oncology Biosimilars Business Introduction
…
Section 4 Global Oncology Biosimilars Market Segmentation (Region Level)
4.1 North America Country
4.1.1 United States Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.1.2 Canada Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.2 South America Country
4.2.1 South America Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.3 Asia Country
4.3.1 China Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.3.2 Japan Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.3.3 India Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.3.4 Korea Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.4 Europe Country
4.4.1 Germany Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.4.2 UK Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.4.3 France Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.4.4 Italy Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.4.5 Europe Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.5 Other Country and Region
4.5.1 Middle East Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.5.2 Africa Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.5.3 GCC Oncology Biosimilars Market Size and Price Analysis 2015-2020
4.6 Global Oncology Biosimilars Market Segmentation (Region Level) Analysis 2015-2020
4.7 Global Oncology Biosimilars Market Segmentation (Region Level) Analysis
Section 5 Global Oncology Biosimilars Market Segmentation (Product Type Level)
5.1 Global Oncology Biosimilars Market Segmentation (Product Type Level) Market Size 2015-2020
5.2 Different Oncology Biosimilars Product Type Price 2015-2020
5.3 Global Oncology Biosimilars Market Segmentation (Product Type Level) Analysis
Section 6 Global Oncology Biosimilars Market Segmentation (Industry Level)
6.1 Global Oncology Biosimilars Market Segmentation (Industry Level) Market Size 2015-2020
6.2 Different Industry Price 2015-2020
6.3 Global Oncology Biosimilars Market Segmentation (Industry Level) Analysis
Section 7 Global Oncology Biosimilars Market Segmentation (Channel Level)
7.1 Global Oncology Biosimilars Market Segmentation (Channel Level) Sales Volume and Share 2015-2020
7.2 Global Oncology Biosimilars Market Segmentation (Channel Level) Analysis
Section 8 Oncology Biosimilars Market Forecast 2020-2025
8.1 Oncology Biosimilars Segmentation Market Forecast (Region Level)
8.2 Oncology Biosimilars Segmentation Market Forecast (Product Type Level)
8.3 Oncology Biosimilars Segmentation Market Forecast (Industry Level)
8.4 Oncology Biosimilars Segmentation Market Forecast (Channel Level)
Section 9 Oncology Biosimilars Segmentation Product Type
9.1 Drug Class - G-CSF Product Introduction
9.2 Monoclonal Antibodies Product Introduction
9.3 Hematopoietic Agents Product Introduction
Section 10 Oncology Biosimilars Segmentation Industry
10.1 Hospital Pharmacy Clients
10.2 Retail Pharmacy Clients
10.3 Online Pharmacy Clients
Section 11 Oncology Biosimilars Cost of Production Analysis
11.1 Raw Material Cost Analysis
11.2 Technology Cost Analysis
11.3 Labor Cost Analysis
11.4 Cost Overview
Section 12 Conclusion
Chart and Figure
Figure Oncology Biosimilars Product Picture from Celltrion Inc.
Chart 2015-2020 Global Manufacturer Oncology Biosimilars Shipments (Units)
Chart 2015-2020 Global Manufacturer Oncology Biosimilars Shipments Share
Chart 2015-2020 Global Manufacturer Oncology Biosimilars Business Revenue (Million USD)
Chart 2015-2020 Global Manufacturer Oncology Biosimilars Business Revenue Share
Chart Celltrion Inc. Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart Celltrion Inc. Oncology Biosimilars Business Distribution
Chart Celltrion Inc. Interview Record (Partly)
Figure Celltrion Inc. Oncology Biosimilars Product Picture
Chart Celltrion Inc. Oncology Biosimilars Business Profile
Table Celltrion Inc. Oncology Biosimilars Product Specification
Chart BioconSTADA Arzneimittel AG Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart BioconSTADA Arzneimittel AG Oncology Biosimilars Business Distribution
Chart BioconSTADA Arzneimittel AG Interview Record (Partly)
Figure BioconSTADA Arzneimittel AG Oncology Biosimilars Product Picture
Chart BioconSTADA Arzneimittel AG Oncology Biosimilars Business Overview
Table BioconSTADA Arzneimittel AG Oncology Biosimilars Product Specification
Chart Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Shipments, Price, Revenue and Gross profit 2015-2020
Chart Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Distribution
Chart Dr. Reddy’s Laboratories Ltd. Interview Record (Partly)
Figure Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Product Picture
Chart Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Business Overview
Table Dr. Reddy’s Laboratories Ltd. Oncology Biosimilars Product Specification
3.4 Pfizer Inc. Oncology Biosimilars Business Introduction
…
Chart United States Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart United States Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Canada Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Canada Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart South America Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart South America Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart China Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart China Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Japan Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Japan Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart India Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart India Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Korea Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Korea Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Germany Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Germany Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart UK Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart UK Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart France Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart France Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Italy Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Italy Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Europe Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Europe Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Middle East Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Middle East Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Africa Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart Africa Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart GCC Oncology Biosimilars Sales Volume (Units) and Market Size (Million $) 2015-2020
Chart GCC Oncology Biosimilars Sales Price ($/Unit) 2015-2020
Chart Global Oncology Biosimilars Market Segmentation (Region Level) Sales Volume 2015-2020
Chart Global Oncology Biosimilars Market Segmentation (Region Level) Market size 2015-2020
Chart Oncology Biosimilars Market Segmentation (Product Type Level) Volume (Units) 2015-2020
Chart Oncology Biosimilars Market Segmentation (Product Type Level) Market Size (Million $) 2015-2020
Chart Different Oncology Biosimilars Product Type Price ($/Unit) 2015-2020
Chart Oncology Biosimilars Market Segmentation (Industry Level) Market Size (Volume) 2015-2020
Chart Oncology Biosimilars Market Segmentation (Industry Level) Market Size (Share) 2015-2020
Chart Oncology Biosimilars Market Segmentation (Industry Level) Market Size (Value) 2015-2020
Chart Global Oncology Biosimilars Market Segmentation (Channel Level) Sales Volume (Units) 2015-2020
Chart Global Oncology Biosimilars Market Segmentation (Channel Level) Share 2015-2020
Chart Oncology Biosimilars Segmentation Market Forecast (Region Level) 2020-2025
Chart Oncology Biosimilars Segmentation Market Forecast (Product Type Level) 2020-2025
Chart Oncology Biosimilars Segmentation Market Forecast (Industry Level) 2020-2025
Chart Oncology Biosimilars Segmentation Market Forecast (Channel Level) 2020-2025
Chart Drug Class - G-CSF Product Figure
Chart Drug Class - G-CSF Product Advantage and Disadvantage Comparison
Chart Monoclonal Antibodies Product Figure
Chart Monoclonal Antibodies Product Advantage and Disadvantage Comparison
Chart Hematopoietic Agents Product Figure
Chart Hematopoietic Agents Product Advantage and Disadvantage Comparison
Chart Hospital Pharmacy Clients
Chart Retail Pharmacy Clients
Chart Online Pharmacy Clients
Research Methodology:
Oncology Biosimilars Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|